In addition to the sales, Oreskovich converted stock options to acquire 16,666 shares at a price of $4.14 per share, amounting to $68,997. Following these transactions, Oreskovich holds 173,642 shares of the company. These transactions were conducted under a pre-established trading plan, ensuring compliance with regulatory requirements. According to InvestingPro analysis, Waystar's stock is currently showing overbought signals, with additional insights available in the comprehensive Pro Research Report covering this $5.86 billion market cap company. According to InvestingPro analysis, Waystar's stock is currently showing overbought signals, with additional insights available in the comprehensive Pro Research Report covering this $5.86 billion market cap company.
In addition to the sales, Oreskovich converted stock options to acquire 16,666 shares at a price of $4.14 per share, amounting to $68,997. Following these transactions, Oreskovich holds 173,642 shares of the company. These transactions were conducted under a pre-established trading plan, ensuring compliance with regulatory requirements.
In other recent news, Waystar Holding has been the recipient of optimistic forecasts and ratings from several financial firms. Raymond (NS:RYMD) James upgraded Waystar from Outperform to Strong Buy, citing the company's potential for sustained double-digit growth and a robust financial profile. This was further supported by the company's Q3 performance, which saw an increase in Net Revenue Retention (NRR) and growth exceeding 20%.
Goldman Sachs raised its price target for Waystar to $39, maintaining a Buy rating, following an impressive Q3 performance and forecast for 2024, suggesting approximately 18% year-over-year growth. This positive outlook was influenced by factors such as accelerated customer growth, a surge in the patient payments segment, and improved net revenue retention.
Additionally, RBC Capital Markets increased its price target to $31, maintaining an Outperform rating, after evaluating Waystar's revenue performance. Barclays (LON:BARC) and BofA Securities initiated coverage on Waystar with an Overweight and Buy rating respectively, focusing on consistent revenue growth and impressive EBITDA margins.
William Blair and Evercore ISI also expressed confidence in Waystar's future, with Blair forecasting significant revenue increases for fiscal years 2024 and 2025, and Evercore upgrading Waystar to an Outperform rating. These recent developments highlight the positive outlook held by various financial firms towards Waystar Holding.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.